These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3110263)

  • 1. In vitro effects of lymphoblastoid interferon on lymphocyte activation and cell-mediated cytolysis in patients with chronic hepatitis B virus infection.
    Alexander GJ; Nouri-Aria KT; Neuberger J; Bakhtiar M; Vogel W; Anderson MG; Magrin S; Eddleston AL; Williams R
    J Hepatol; 1986; 3 Suppl 2():S269-77. PubMed ID: 3110263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic active hepatitis B. Interferon-activated natural killer-like cells against a hepatoma cell line transfected with the hepatitis B virus nucleic acid.
    Actis GC; Ponzetto A; D'Urso N; Saracco G; Crepaldi T; Bellone G; Catucci LM; Zarcone D; Verme G
    Liver; 1991 Apr; 11(2):106-13. PubMed ID: 1646927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro effect of lymphoblastoid alpha-interferon on subpopulations of effector cells mediating cytotoxicity for autologous hepatocytes in hepatitis B and non-A, non-B.
    Mondelli MU; Alberti A; Realdi G; Rondanelli EG
    Int J Immunopharmacol; 1986; 8(8):887-91. PubMed ID: 3100465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon-γ or interleukin-10 are expanded in asymptomatic, E antigen-negative patients with persistent hepatitis B virus infection.
    Conroy MJ; Mac Nicholas R; Grealy R; Taylor M; Otegbayo JA; O'Dea S; Mulcahy F; Ryan T; Norris S; Doherty DG
    J Viral Hepat; 2015 Mar; 22(3):335-45. PubMed ID: 25186004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a deficiency of interferon production in patients with chronic hepatitis B virus infection acquired in adult life.
    Ikeda T; Lever AM; Thomas HC
    Hepatology; 1986; 6(5):962-5. PubMed ID: 2428724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune effects of alpha-interferon in chronic liver disease.
    Peters M; Walling DM; Waggoner J; Avigan MI; Sjogren M; Hoofnagle JH
    J Hepatol; 1986; 3 Suppl 2():S283-9. PubMed ID: 3598159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunologic staging of chronic active hepatitis B patients in Hawaii.
    Ching N; Lumeng J; Pon E; Ching CY
    Hawaii Med J; 1994 Feb; 53(2):44-5, 49. PubMed ID: 7514583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of interferon-alpha treatment on hepatitis B virus antigen-specific immunologic responses in patients with chronic hepatitis B.
    Ishikawa T; Kakumu S; Yoshioka K; Kurokawa S; Kusakabe A; Tahara H; Hirofuji H; Kawabe M
    Liver; 1993 Apr; 13(2):95-101. PubMed ID: 8510492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulation of human leukocytes by staphylococcal enterotoxin A: augmentation of natural killer cells and induction of suppressor cells.
    Platsoucas CD; Oleszak EL; Good RA
    Cell Immunol; 1986 Feb; 97(2):371-85. PubMed ID: 2943428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of chronic hepatitis B with human lymphoblastoid interferon: results of a controlled trial.
    Mazzella G; Villanova N; Abdu-Ahmed M; Barbara L; Saracco G; Rizzetto M; Cancellieri C; Roda E
    Chemioterapia; 1988 Dec; 7 Suppl 3():12-4. PubMed ID: 3073868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rotavirus induces proliferative response and augments non-specific cytotoxic activity of lymphocytes in humans.
    Yasukawa M; Nakagomi O; Kobayashi Y
    Clin Exp Immunol; 1990 Apr; 80(1):49-55. PubMed ID: 2157566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune mechanisms and the action of interferon in chronic hepatitis B virus infection.
    Vladutiu AO
    Immunol Commun; 1978; 7(4):371-82. PubMed ID: 352919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibody-dependent cell cytotoxicity and the effect of interferon on K-cell functional activity in vitro in chronic viral hepatitis B in children].
    Kaganov BS; Zimin IuI; Uchaĭkin VF; Saidov MZ; Sorokin AM
    Biull Eksp Biol Med; 1984 Dec; 98(12):700-2. PubMed ID: 6509200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro alpha-interferon treatment of peripheral blood mononuclear cells improves interleukin-2 activity in HBV-related chronic liver disease.
    Saxena S; Nouri-Aria KT; Anderson MG; Williams R; Eddleston AL
    J Hepatol; 1985; 1(4):385-93. PubMed ID: 3877114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological studies in patients with HBsAg-positive chronic active hepatitis--spontaneous lymphocyte transformation and natural killer cell activity.
    Koo JY; Park BC; Chung JM
    Korean J Intern Med; 1987 Jul; 2(2):221-6. PubMed ID: 3154834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T lymphocyte subsets implicated in cytotoxicity in autologous hepatocytes in chronic active hepatitis patients with active viral replication.
    Stefanini GF; Mazzetti M; Zunarelli P; Baraldini M; Pignatelli M; Canonica GW; Miglio F; Gasbarrini G
    Clin Immunol Immunopathol; 1986 Aug; 40(2):214-23. PubMed ID: 3487403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired in vitro interferon, blastogenic, and natural killer cell responses to viral stimulation in acquired immune deficiency syndrome.
    Hersh EM; Gutterman JU; Spector S; Friedman H; Greenberg SB; Reuben JM; LaPushin R; Matza M; Mansell PW
    Cancer Res; 1985 Jan; 45(1):406-10. PubMed ID: 2578099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection.
    Rehermann B; Lau D; Hoofnagle JH; Chisari FV
    J Clin Invest; 1996 Apr; 97(7):1655-65. PubMed ID: 8601631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection.
    Alexander GJ; Brahm J; Fagan EA; Smith HM; Daniels HM; Eddleston AL; Williams R
    Lancet; 1987 Jul; 2(8550):66-9. PubMed ID: 2885573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological studies before and during interferon therapy in chronic HBV infection: identification of factors predicting response.
    Scully LJ; Brown D; Lloyd C; Shein R; Thomas HC
    Hepatology; 1990 Nov; 12(5):1111-7. PubMed ID: 1699861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.